The subtype and the expression of the a2-adrenergic receptor were investigated in the normal mucosa from human intestine by means ofradioligand binding, RNase mapping, and measurement of adenylate cyclase activity. The study of the binding of the a2-adrenergic antagonist, [3HIRX821002, to epithelial cell membranes indicated the existence of a single class of noninteracting sites displaying a high affinity for the radioligand (Kd = 1.1±0.5 nM). The rank order of potency of antagonists to inhibit 13HIRX821002 binding (RX821002 > yohimbine = rauwolscine > phentolamine idazoxan > chlorpromazine > prazosin) suggested that the receptor is of the a2A subtype. A conclusion which is confirmed by the fact that only a2ClO transcripts were found in the human intestine mucosa. Competition curves with (-)-norepinephrine demonstrated that 60% of the receptor population exhibited high affinity for agonists. This high-affinity state was abolished by the addition of GTP plus Na+ or by prior treatment of the membranes with pertussis toxin indicating it corresponded to G protein-coupled receptors. 132PJADP-ribosylation and immunoblotting experiments identified two pertussis toxin-sensitive G proteins corresponding to Gi2 and Gi3. The study of the distribution of the receptor indicated that (a) the proximal colon is the intestine segment exhibiting the highest receptor density and (b) the receptor is predominantly expressed in crypts and is preferentially located in the basolateral membrane of the polarized cell. The distribution of the receptor along the crypt-surface axis of the colon mucosa can be correlated with a higher level of a2clo-specific mRNA and a higher efficiency of UK14304 to inhibit adenylate cyclase in crypt cells. (J. Clin.
Introduction
Several observations indicate that catecholamines play a physiological role in the regulation of water and electrolyte fluxes across the intestinal epithelium (1) . The intestinal mucosa is extensively innervated by noradrenergic fibers and high levels Receivedfor publication 12 May 1992 and in revisedform 23 November 1992. of catecholamines can be potentially achieved at the vicinity of the epithelial cells (2) . In vitro experiments on isolated intestinal loops demonstrated that the addition ofexogenous norepinephrine (3) or the stimulation ofendogenous norepinephrine release by tyramine (4) increased the net absorption of Na', Cl-, and fluid. Finally, the diarrhea observed in rats made diabetic with streptozocin is due to a loss of the noradrenergic innervation of the enterocytes (5) . The use of selective adrenergic drugs proved the antisecretory action of catecholamines to be at least partially mediated by the stimulation of postsynaptic a2-adrenergic receptors located on the epithelial cells (6) (7) (8) . Direct evidence for the presence of a2-adrenergic receptors on intestinal epithelial cells from different species was subsequently brought by the use of selective radioligands (9) (10) (11) (12) (13) .
The antisecretory properties of a2-agonists led to propose these compounds as a promising new class of antidiarrheal drugs in humans 14, 15) . In this respect, clonidine and lindamidine were shown to represent a reasonable alternative for the treatment of certain forms of chronic diarrhea ( 16, 17) . However, there are so far no direct data supporting the existence of a2-adrenergic receptors in epithelial cells from human intestine. Given the pharmacological heterogeneity ofa2-adrenergic receptors ( 18), the present study was performed in order to define the subtype of the a2-adrenergic receptor expressed in this tissue. The coupling ofthe receptor to G proteins and adenylate cyclase was investigated. Moreover, the level of expression ofthe receptor was studied along the crypt-surface axis of the mucosa and along the oral-aboral axis of the intestinal tract.
Methods
Sources oftissues. Whole intestinal tracts (n = 6) came from irreversibly brain-damaged cadaveric organ donors. These samples were obtained thanks to the collaboration of the French institution FranceTransplant (Paris) and were collected within 2 h after death. Additional colon mucosa specimens (n = 21 ) were obtained from patients who underwent surgical resection of colorectal carcinoma. In this later case, histological examination was performed and only the segments with normal mucosa were retained.
Isolation of epithelial cells and membrane preparation. Epithelial cells were isolated from the intestinal mucosa as previously described by Laburthe et al. ( 19) . Intestine segments were flushed free ofcontent with cold PBS, then everted, and washed twice in the same solution.
The following steps ofthe preparation were carried out at 4°C. Epithelial cells were isolated by shaking the everted intestine in a dispersing solution containing 2.5 mM EDTA and 0.24 M NaCl (pH 7.5). Cells were collected by centrifugation and pellets were washed once in PBS.
In some experiments, crypt cells were separated from villus cells by sequential isolation exactly as reported in ( 12) . This procedure generated four fractions (I-IV) displaying different degrees of differentiation. Crude membranes were prepared as in Laburthe et al. (20) , and the final membrane pellets were frozen at -80'C until their use for binding studies, G-protein identification, or measurement ofadenylate cyclase activity.
Purification ofbrush border and basolateral membranes. Purified membrane fractions were prepared essentially as described by Schmitz et al. (21 ) . Freshly isolated cells were homogenized in 2 mM Tris-HCI buffer (pH 7.4) containing 300 mM mannitol with a Blendor (Waring, New Hartford, CT). The homogenate was chilled at 4VC and CaCl2 was added at a final concentration of 10 mM. After standing for 15 min, the Ca" -treated homogenate was centrifuged 15 min at 3,000 g. The resulting pellet (P1) containing the basolateral membranes was washed once and resuspended in Tris-Mg++ buffer for determination of binding site number. The supernatant (Sl) was collected and centrifuged 10 min at 27,000 g. The pellet (P2) containing the brush border membrane vesicles was submitted to two additional cycles of suspension/ centrifugation in order to increase the purity of the preparation and then resuspended as above for use in binding experiments.
Binding studies. Binding experiments were conducted as previously described (22) . Briefly, 100 jil of membrane suspension was incubated at 250C in the presence of the radioligand in a 400-Al final volume of Tris-Mg++ buffer (50 mM Tris-HCI, 0.5 mM MgCI2, pH 7.5) containing 0.1 mM pyrocatechol, 0.8 mM DTT, and 0.3 mM ascorbic acid. The addition ofthese protectors was necessary because of high level of monoamine oxidase and catechol-O-methyl transferase activity in the preparations. It did not modify the binding parameters of the radioligand (23) . After a 45-min period of incubation, membranebound radioligand was separated from free by rapid filtration through GF/C filters (Whatman Inc., Clifton, NJ) using a cell harvester (Skatron, Inc., Sterling, VA). Filters were washed with cold Tris-Mg++ buffer, air-dried, transferred into vials, and counted for radioactivity by liquid scintillation spectrometry. Specific binding was defined as the difference between total and nonspecific binding determined in presence of 10-4 M (-)-epinephrine. For (24) . Inhibition studies were carried out at a radioligand concentration of 2.5-3 nM. According to the Hill coefficient value (nH), the data were analyzed using either the TWOSITEINHIB or INHIBITION program allowing curve fitting to a two-site or a one-site inhibition model (25) . The inhibition constants (K1) were calculated from IC50 values using the equation of Cheng and Prussoff (26) .
[32P]ADP-ribosylation by pertussis toxin. Pertussis toxin-catalyzed [32PIADP-ribosylation experiments were performed as described by Immunoblotting ofa subunits ofG proteins. The method used was that described by Homburger et al. (28) . Membrane Bradford (36) . The activity of alkaline phosphatase was estimated using the method of Garen and Levinthal (37 (Fig. 3) indicative ofthe existence ofan heterogeneous population ofbinding sites for agonists. Computer-assisted analysis ofthe data obtained in the duodenum, jejunum, ileum, and colon were better fitted with a two-site than with a one-site inhibition model. The calculated values of the inhibition constants of (-)-norepinephrine at the high-and low-affinity state receptor are reported in Table II . The percentage of high-affinity state receptors represented 60% of the whole receptor population. Addition of 10-4 M GTP and 100 mM NaCl shifted the inhibition curves to the right (Fig. 3) . The Hill coefficient values were increased and the whole receptor population was converted into a low-affinity conformation (Table II) (Fig. 4) . Comparison ofthe relative mobility of these proteins with that of the proteins labeled in membranes from rat jejunum mucosa (a tissue which expresses ai2 and ai3) and from bovine brain (a tissue which expresses ail, ai2, ai3, and a0) indicated that the band of greater mobility corresponded to ai2. Since there are two 41-kD peptides (ai 1 and ai3) which are substrates for pertussis toxin, the exact nature of the second band needed to be identified by immunodetection with specific antibodies (Fig.  5) . Immunoblotting with the anti-ail /ai2 antiserum (AS7) revealed the presence of a single immunoreactive peptide corresponding to ai2 and suggested that the second polypeptide labeled by pertussis toxin is ai3. The presence of ai3 was confirmed by the use of an anti-aO/ai3 antiserum (EC2). Thus, human enterocytes and colonocytes express Gi2 and Gi3, but not Gil and GO. Distribution and subcellular localization ofthe a2-adrenergic receptor. Previous reports on rat jejunum ( 12) and on rabbit colon ( 13) have shown the existence of an heterogenous distribution ofthe a2-adrenergic receptor along the villus-crypt axis of the intestinal mucosa. Further experiments were performed to see whether this was also the case in humans. In this series of experiments, we also examined the level ofexpression ofthe receptor in the different segments ofthe intestinal tract as well as its subcellular localization in the polarized cell.
Results from the quantification ofthe receptor in the different segments of the gut are summarized in the Table III . As already noted in experiments dealing with the characterization of the receptor, it is obvious that the level of expression of the The binding parameters of( -)-norepinephrine calculated from computerized analysis ofthe curves are summarized in Table II. receptor widely varies according to the segment considered. In the small intestine, duodenum was the segment expressing the highest level ofreceptors. A twofold lower density was found in jejunum and only trace amounts were detectable in ileum. In the large bowel, the density of receptor which was maximal in the proximal segment, then slowly decreased in transverse and distal segments. Whatever the segment considered there was no change in the Kd value ofthe radioligand and yohimbine was a thousandfold more potent than prazosin to inhibit [3H]-RX821002 binding indicating that the same receptor subtype was expressed through the whole intestinal tract.
There is so far no data dealing with the subcellular distribution of the a2-adrenergic receptor in polarized cells. The localization ofthe receptor was studied by measuring the number of
[3H]RX821002 binding sites in basolateral and brush border membranes prepared from epithelial cells of the proximal colon mucosa. The results from this study are summarized in the Table IV . As expected the brush border membrane-enriched fraction exhibited a very high level of alkaline phosphatase activity. This increase in the specific activity of the enzyme was associated with a decrease in capacity to bind the labeled a2 antagonist. Conversely, the basolateral membrane fraction displayed a reduced phosphatase activity and a higher binding site number. The a2-adrenergic receptor is therefore preferentially located in the basolateral compartment of the polarized intestinal cell.
The distribution of a2-adrenergic receptors along the crypt to surface axis was investigated in duodenum and proximal colon by studying [3H]RX821002 binding on four different membrane fractions generated by sequential isolation of the epithelial cells (Fig. 6 ). The alkaline phosphatase activity was measured as an index of cell differentiation. In both segments, the activity ofthe enzyme was higher in fractions I and II corresponding to surface cells than in fractions III and IV which are enriched in crypt cells. 
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Membranes prepared from duodenum, jejunum, ileum, and colon epithelium were incubated with [3H]RX821002 and increasing concentrations of (-)-norepinephrine as described in the Fig. 2 . According to the Hill coefficient value (nH), inhibition curves in the absence of GTP and Na' were better fitted by a two-site inhibition model and constant values were calculated using TWOSITEINHIB (25) . Inhibition data in the presence of GTP plus Na' were consistent with the existence of a single class of sites and were analyzed using INHIBITION (25 quences of this heterogenous distribution. All these experiments were performed on cell fractions isolated from the proximal colon. RNase mapping experiments were carried out using the radioprobes a2C1OAR352 to quantify the a2A-adrenergic receptor mRNA and 36B4 as an internal standard to verify the quality ofthe RNA preparations (Fig. 7) . Analysis ofthe autoradiograms from five independent experiments clearly showed that the amount of a2cIo transcripts was higher in crypt than in surface cells. There is therefore a correlation between the level ofexpression ofthe receptor and the amount ofits mRNA. The biological efficacy of the receptor was estimated in cell fractions I (surface cells) and IV (crypt cells) by measuring the inhibitory effect of UK14304 on forskolin-stimulated adenylate cyclase. As reported in the Fig. 8 , the basal activity of the enzyme was similar in both membrane preparations (5 ments which demonstrated that the a2C10 gene, but not the a2c2 or a2C4, was expressed in intestinal mucosa.
The biochemical mechanisms whereby a2-adrenergic receptor stimulation inhibits intestinal secretions are still matter of controversy. The receptor was shown to be negatively coupled to adenylate cyclase in human colonic crypts (38) and in the colon adenocarcinoma cell line HT29 (39). Nakaki and co-workers (9) proposed the effect of a2 agonists on secretions to be triggered by cAMP-independent mechanisms. Other mechanisms that were proposed include interference with Ca" -dependent pathways (40) and a direct coupling ofG proteins to a ion channel (1) . Interestingly, a GTP-sensitive Clchannel distinct from the cAMP-dependent Cl-channel was recently characterized in the apical membranes of differentiated HT29 cells (41) . As shown by the present data, the human intestinal a2-adrenergic receptor is coupled to pertussis toxin-sensible G proteins which were identified as Gi2 and Gi3. Experiments on reconstituted systems (42) or on native membranes (43) have demonstrated that the a2-adrenergic receptor can interact with multiple Gi proteins, each playing an individual function in signal transduction. According to this later point, Gi2 is thought to be preferentially responsible for Epithelial cells were isolated from the proximal colon mucosa, then crude and purified membranes were prepared as described in Methods. The density of a2-adrenergic receptor was determined using
[3H]RX821002 and alkaline phosphatase activity measured using pnitrophenyl phosphate as substrate (37) . Reported values are means±SE from three independent experiments. the inhibition of adenylate cyclase (44) , whereas Gi3 would be more specifically involved in the regulation of ion-channel activity (45) . The discrete role of Gi2 and Gi3 in the human mucosa needs complementary work to be elucidated, but the preferential coupling of Gi3 to a Cl-channel could represent an interesting working hypothesis for the future. Also, recent data from our groups have demonstrated that in the rat jejunum mucosa the expression of both Gi2 and Gi3 is higher in villi than in crypts (46) . The possibility of a similar distribution remains to be established in human. The second aim ofthis work was to study the distribution of a2-adrenergic receptors in the intestinal mucosa. In the small intestine, a2-adrenergic receptor number decreases from duodenum to ileum. A similar decrease was also observed from the proximal to the distal colon. Moreover, in proximal and transverse colon the density in a2-adrenergic receptors was at least threefold higher than in small bowell. The physiological relevance of such a distribution remains unclear since a wide number of factors are involved in the regulation of water and electrolytes absorption. The abundance ofreceptor in the proximal colon is, however, consistent with the crucial role of this large bowel segment in the regulation of water absorption.
The study of the distribution of the a2-adrenergic receptor within duodenal and colonic mucosa showed that the receptor is preferentially expressed in crypts, where it is negatively coupled to adenylate cyclase. A similar pattern of distribution was also found in rat jejunum (12) and rabbit colon (13 (49) . The presence of a2-adrenergic receptors on crypt cells which are immature proliferating cells also raises the question of a possible involvement ofthis receptivity in the regulation of their mitogenic activity. Such a role has not yet been explored in detail. Three pieces of data may, however, support this hypothesis. First, low levels of cyclic AMP have been correlated with the high rate of cell division in crypt cells (50) . Secondly, a2 agonists were shown to act as co-mitogen in fibroblasts transfected with the a2-adrenergic gene a2ClO (51 ) . Finally, in vivo studies on rat have shown that infusion of noradrenaline accelerates crypt cell proliferation in jejunum (52) . This effect was, moreover, demonstrated to be triggered through the stimulation of receptors displaying an a2-adrenergic pharmacology.
